Integrated versus Nonintegrated Peripheral Intravenous Catheters: OPTIMUM Trial - A Randomized Controlled Trial

Name: Integrated versus Nonintegrated Peripheral Intravenous Catheters: OPTIMUM Trial - A Randomized Controlled Trial
Start: 2026-11-03
End: 2026-11-03

Starts: November 3, 2026
Ends: November 3, 2026
Format: Online
Location: VIRTUAL

About This Event

This session is reporting the results of a randomized controlled trial of 1759 patients to compare integrated vs non-integrated PIVs in adult patients. The primary outcome was device failure (composite: occlusion, infiltration, phlebitis, dislodgement, local, or bloodstream infection). Infection endpoints were assessor masked. The secondary outcomes were: failure type, first‐time insertion success, tip colonization, insertion pain, dwell time, mortality, costs, health‐related quality of life, clinician, and patient satisfaction.